(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.

Meta to Spend Up to $27 Billion on Nebius AI Infrastructure
15:55

Adobe CEO to Step Down in Face of Investor Concerns Over AI
18:19

Dick’s Projects Sales Growth at Namesake Stores, Foot Locker
14:01